Search by Drug Name or NDC
NDC 63323-0539-03 Enoxaparin Sodium 300 mg/3mL Details
Enoxaparin Sodium 300 mg/3mL
Enoxaparin Sodium is a INTRAVENOUS; SUBCUTANEOUS INJECTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Fresenius Kabi USA, LLC. The primary component is ENOXAPARIN SODIUM.
MedlinePlus Drug Summary
Enoxaparin is used to prevent blood clots in the leg in patients who are on bedrest or who are having hip replacement, knee replacement, or stomach surgery. It is used in combination with aspirin to prevent complications from angina (chest pain) and heart attacks. It is also used in combination with warfarin to treat blood clots in the leg. Enoxaparin is in a class of medications called low molecular weight heparins. It works by stopping the formation of substances that cause clots.
Related Packages: 63323-0539-03Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Enoxaparin Injection
Product Information
| NDC | 63323-0539 |
|---|---|
| Product ID | 63323-539_f1604264-1625-131c-e053-2a95a90a897c |
| Associated GPIs | 83101020102050 |
| GCN Sequence Number | 038895 |
| GCN Sequence Number Description | enoxaparin sodium VIAL 300 MG/3ML SUBCUT |
| HIC3 | M9K |
| HIC3 Description | HEPARIN AND RELATED PREPARATIONS |
| GCN | 96334 |
| HICL Sequence Number | 007878 |
| HICL Sequence Number Description | ENOXAPARIN SODIUM |
| Brand/Generic | Generic |
| Proprietary Name | Enoxaparin Sodium |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | enoxaparin sodium |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION |
| Route | INTRAVENOUS; SUBCUTANEOUS |
| Active Ingredient Strength | 300 |
| Active Ingredient Units | mg/3mL |
| Substance Name | ENOXAPARIN SODIUM |
| Labeler Name | Fresenius Kabi USA, LLC |
| Pharmaceutical Class | Heparin, Low-Molecular-Weight [CS], Low Molecular Weight Heparin [EPC] |
| DEA Schedule | n/a |
| Marketing Category | NDA AUTHORIZED GENERIC |
| Application Number | NDA020164 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 63323-0539-03 (63323053903)
| NDC Package Code | 63323-539-03 |
|---|---|
| Billing NDC | 63323053903 |
| Package | 1 VIAL, MULTI-DOSE in 1 CARTON (63323-539-03) / 3 mL in 1 VIAL, MULTI-DOSE |
| Marketing Start Date | 2019-06-18 |
| NDC Exclude Flag | N |
| Pricing Information | |
| Price Per Unit | 13.428 |
| Pricing Unit | ML |
| Effective Date | 2022-06-22 |
| NDC Description | ENOXAPARIN 300 MG/3 ML VIAL |
| Pharmacy Type Indicator | C/I |
| OTC | N |
| Explanation Code | 4, 5, 6 |
| Classification for Rate Setting | G |
| As of Date | 2022-11-23 |
This pricing file, entitled the NADAC (National Average Drug Acquisition
Cost) files, provide
state Medicaid agencies with covered outpatient drug prices by averaging
survey invoice
prices from retail community pharmacies across the United States. These
pharmacies include
independent retail community pharmacies and chain pharmacies. The prices
are updated on a
weekly and monthly basis